Compare LCUT & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LCUT | ALEC |
|---|---|---|
| Founded | 1945 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.1M | 167.6M |
| IPO Year | 1996 | 2019 |
| Metric | LCUT | ALEC |
|---|---|---|
| Price | $9.19 | $1.78 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $5.00 | $4.83 |
| AVG Volume (30 Days) | 135.5K | ★ 709.7K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.54% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | ★ $647,933,000.00 | $21,045,000.00 |
| Revenue This Year | $3.74 | $2.03 |
| Revenue Next Year | $1.20 | $29.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.90 | $1.09 |
| 52 Week High | $10.03 | $3.40 |
| Indicator | LCUT | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 53.45 | 58.43 |
| Support Level | $7.57 | $1.75 |
| Resistance Level | $9.19 | $2.10 |
| Average True Range (ATR) | 0.55 | 0.13 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 32.14 | 52.58 |
Lifetime Brands Inc is a U.S.-based company that designs, sources, and sells branded kitchenware, tableware, and other home solution products used in the home. The company's product portfolio comprises kitchen tools, cutlery, thermometers, cutting boards, spice racks, dinnerware, stemware, flatware, bath scales, thermal beverage ware, food storage, neoprene travel products, etc. These products are marketed under owned or licensed brands like Farberware, KitchenAid, Mikasa, Misto, Taylor, Sabatier, and Pfaltzgraff, among others. The company mainly sells its products directly to retailers and distributors, and a limited selection directly to consumers through its own websites. It has two reportable operating segments: U.S., which derives maximum revenue, and International.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.